{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-070157","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2023-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.925316+00:00","generated_at":"2026-06-14T02:52:50.304688+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cognition Therapeutics reports 2023 annual meeting vote results","bullets":["Annual Meeting held June 9, 2023; virtual format.","Aaron Fletcher and Lisa Ricciardi elected Class II directors with 11,466,658 and 10,596,682 votes for, respectively.","Ratification of Ernst & Young as independent auditor passed with 19,173,712 votes for, 13,668 against, 43,820 abstain.","Broker non-votes on director election: 7,212,602 each; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-070157","json":"https://secwatch.observer/filing/0001104659-23-070157.json","markdown":"https://secwatch.observer/filing/0001104659-23-070157.md","text":"https://secwatch.observer/filing/0001104659-23-070157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923070157/0001104659-23-070157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923070157/tm2318411d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T02:52:50.304688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c85851ada13be33a5d708224dc43313999edaf6","claim":"COGNITION THERAPEUTICS INC shareholders approved Election of Class II Directors. at the 2023-06-09 meeting.","evidence_excerpt":"Proposal 1 – Election of Class II Directors. Each of Aaron Fletcher and Lisa Ricciardi were elected to the Board of Directors as Class II directors to serve until the Company’s 2026 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal as follows: Name For Withheld Broker Non-Votes Aaron Fletcher 11,466,658 551,940 7,212,602 Lisa Ricciardi 10,596,682 1,421,916 7,212,602","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923070157/0001104659-23-070157-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"bed61b2258eab74fe64fd4f0b27d565455aa6972","claim":"COGNITION THERAPEUTICS INC shareholders approved Ratification of Independent Registered Public Accountants. at the 2023-06-09 meeting.","evidence_excerpt":"Proposal 2 – Ratification of Independent Registered Public Accountants. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year was ratified, as follows: For Against Abstentions Broker Non-Votes 19,173,712 13,668 43,820 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923070157/0001104659-23-070157-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}